Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNLG.L Regulatory News (NLG)

  • There is currently no data for NLG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Financing update

3 Oct 2016 07:00

RNS Number : 4508L
Arria NLG PLC
03 October 2016
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO, OR FROM ANY JURSIDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATIONS (EU) NO. 596/2014 ("MAR")

 

 

3 October 2016

 

Arria NLG plc

("Arria NLG" or the "Company")

 

Financing update

 

Arria NLG (AIM: NLG), a world leader in artificial intelligence and natural language generation ("NLG"), is pleased to announce that it has reached agreement with investors, subject to the completion of the relevant documentation, for the subscription of approximately £2.7 million of unsecured convertible loan notes ("Loan Notes") with C warrants attached. The subscribers include existing and new investors in the Company.

 

The terms of the Loan Notes are substantially the same as those announced on 29 June 2015 and in summary the key terms are as follows:

 

· interest at the Bank of England base rate (currently 0.25%) plus 5%, payable in cash, either annually or upon maturity (at the Company's election);

· maturity date of 31 October 2019 with the Company having a right to make repayment before the maturity date; and

· convertible in to new ordinary shares in the Company at a price of 40p per new ordinary share. Loan Note holders are able to convert their Loan Note principal and any unpaid interest into new ordinary shares in the Company shortly before repayment or the maturity date, and annually during a specified window.

 

Subscribers for the Loan Notes will receive two unlisted warrants to subscribe for new ordinary shares in the Company for each US$1.00 invested in the Loan notes, exercisable up to 11 June 2019, at 12p per new ordinary share (the "C Warrants").

 

The proceeds of the issue of Loan Notes will be applied to satisfy the Company's general short term working capital requirements.

 

As previously announced, the Company continues to advance its plans for the listing of the securities of a new New Zealand holding company ("Arria NLG Group") on the main board of the New Zealand Stock Exchange and secondary listings on the Australian Securities Exchange and the standard segment of the Main Market of the London Stock Exchange plc (together, the "Listings"). Further announcements will be made in due course.

 

The Company also advises that under the subscription and sharing agreements between the Company and Lanstead Capital L.P. ("Lanstead"), details of which were announced on 15 October 2015, the monthly payments under the sharing agreements commenced during February 2016 and have continued since. To date the Company has received £1.58 million from Lanstead under the sharing agreements.

 

Sharon Daniels, Chairman and Interim Chief Executive Officer of Arria NLG, commented: "We are very pleased by the support we have received from Lanstead and other existing and new shareholders. The Listing process is progressing and we look forward to providing further details over the coming weeks."

 

 

For further information, please visit www.arria.com or contact:

Arria NLG plc - Chairman and Interim Chief Executive

Sharon Daniels

Tel +44 (0)20 7100 4540

Allenby Capital (Nominated Adviser & Joint Broker)

Nick Naylor

Jeremy Porter

James Reeve

Tel: +44 (0)20 3328 5656

MSL Capital Markets (Lead Manager)

Andrew McDouall

Justine Dunnett

Peter Lynds

Tel: +64 (0)4 472 2716

Stockdale Securities (Joint Broker)

Antonio Bossi

Robert Finlay

Tel: +44 (0)20 7601 6100

IFC Advisory (Financial PR and IR)

Tim Metcalfe

Graham Herring

Heather Armstrong

Tel: +44 (0)20 3053 8671

tim.metcalfe@investor-focus.co.uk

graham.herring@investor-focus.co.uk

heather.armstrong@investor-focus.co.uk

Ruder Finn (PR USA)

Scott Beaver (West Coast)

Brianna Mulligan (East Coast)

 

Tel: +1 541-326-5847

Tel: +1 203-246-1304

 

 

Arria NLG

 

Arria NLG's core product is known as the Arria NLG Platform, a form of artificial intelligence software, specialised in extracting information from complex data sources and communicating that information in natural language (i.e. as if written by a human). The scientific foundation for the Arria NLG Platform is based on more than 30 years of research and development by the Arria|Data2Text Founders at the University of Aberdeen. For additional information, visit www.arria.com. Follow Arria NLG on Twitter, LinkedIn, Google+ and YouTube.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEANEAEESKFFF
Date   Source Headline
12th Nov 20155:24 pmRNSHolding(s) in Company
6th Nov 20154:12 pmRNSResult of GM, funding update & total voting rights
30th Oct 20155:54 pmRNSTotal Voting Rights
20th Oct 20154:26 pmRNSPosting of Circular and Notice of General Meeting
20th Oct 201510:00 amRNSHolding(s) in Company
15th Oct 20157:00 amRNSSubscription agreement with Lanstead Capital
29th Sep 20157:00 amRNSGrant of Additional US Patent
14th Sep 201512:13 pmRNSBoard Appointment
2nd Sep 20151:47 pmRNSCapital Funding Update
21st Aug 20157:00 amRNSNew Agreement with a Consumer Goods Company
19th Aug 20158:56 amRNSFunding Update
4th Aug 201510:01 amRNSGrant of US patent
4th Aug 201510:00 amRNSFunding update
30th Jun 20154:15 pmRNSCorrection: £3.75 Million Raised
30th Jun 20154:15 pmRNSCorrection: Interim Results
30th Jun 20157:00 amRNSInterim Results
29th Jun 20157:32 amRNS£3.75 Million Raised
24th Jun 20157:00 amRNSFunding update
18th Jun 20157:00 amRNSNew Agreement with Major Online Travel Company
4th Jun 20154:40 pmRNSSecond Price Monitoring Extn
4th Jun 20154:35 pmRNSPrice Monitoring Extension
3rd Jun 20157:00 amRNSUpdate Regarding Further Funding
13th May 20154:40 pmRNSSecond Price Monitoring Extn
13th May 20154:35 pmRNSPrice Monitoring Extension
13th May 20157:00 amRNSProof of Concept Pilot Agreement
12th May 20154:40 pmRNSSecond Price Monitoring Extn
12th May 20154:35 pmRNSPrice Monitoring Extension
11th May 20157:00 amRNSLicensing Agreement with MeteoGroup UK
5th May 20157:02 amRNSExhibit at World of Watson
30th Apr 20157:00 amRNSRe Contract and Trading Update
8th Apr 20157:00 amRNSUK Met Office Contract Extension
23rd Mar 20157:00 amRNSFramework Licensing Agreement
3rd Mar 20157:00 amRNSBG Group. Heads of Agreement
2nd Mar 20157:00 amRNSFive Year Licensing Agreement with FarmLink, LLC.
27th Feb 201512:30 pmRNSTotal Voting Rights
4th Feb 20157:00 amRNSSubscription to raise £408,270
27th Jan 20152:32 pmRNSResult of AGM
27th Jan 20152:05 pmRNSAGM Statement
26th Jan 20157:00 amRNSIBM Watson Partnership Agreement
15th Jan 20157:00 amRNSNew Agreement with Major Insurance Company
17th Dec 20147:00 amRNSNew Oil & Gas Client
12th Dec 20147:00 amRNSFinal Results
14th Oct 20147:00 amRNSAgreement with Leading Aviation Systems Provider
13th Oct 20147:00 amRNSContract signed with FarmLink, Inc.
1st Oct 20147:00 amRNSConvertible loan notes to raise circa US$5.0m
9th Sep 20147:00 amRNSAIM Awards 2014 Nomination - Best Technology
12th Aug 20147:00 amRNSProject with Global Financial Services Company
25th Jun 20147:00 amRNSJohn Bell strengthens growing Sales Force
24th Jun 20147:00 amRNSAwarded two US Patents
23rd Jun 20143:10 pmRNSPosting of interim accounts

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.